Follow The Filings

GRAL GRAIL

GRAIL earnings company data as of 7:48 PM ET 11/13

  • 0 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS -1.90 -2.21 Miss
Rev $44.1M $37.5M Miss -14.8%

Insider trades

Open-market buys and sales by GRAL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GRAL insider trades
  • None no insider bought on the open market
  • $7.6M sold by 3 insiders outside a trading plan
  • $10.5M sold by 2 insiders under 10b5-1 plans
  1. Aaron Freidin CFO
    Planned sale
    $323K 3,000 shares at $107.62 1.3% of stake
    Traded Nov 16 Filed Nov 16
  2. Joshua J. Ofman CEO
    Planned sale
    $2.7M 20,000 shares at $136.85 5.5% of stake
    Traded Oct 15 Filed Oct 16
  3. Aaron Freidin CFO
    Planned sale
    $383K 4,100 shares at $93.34 1.6% of stake
    Traded Sep 21 Filed Sep 23
  4. Joshua J. Ofman CEO
    Planned sale
    $6M 61,452 shares at $97.74 15% of stake
    Traded Sep 21 Filed Sep 23
  5. Joshua J. Ofman CEO
    Planned sale
    $425K 5,000 shares at $85.02 1.2% of stake
    Traded Aug 27 Filed Aug 31
  6. Aaron Freidin CFO
    Planned sale
    $672K 7,900 shares at $85.01 3% of stake
    Traded Aug 27 Filed Aug 31
  7. Joshua J. Ofman President
    Sale
    $1.3M 13,000 shares at $100.00 3.4% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
  8. Robert P. Ragusa CEO
    Sale
    $3.8M 40,000 shares at $95.24 5.5% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
  9. Aaron Freidin CFO
    Sale
    $2.5M 25,000 shares at $99.15 8.8% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
  10. Illumina, Inc. 10% owner
    Sale
    $79.8M 1,000,000 shares at $79.85 22% of stake
    Traded Nov 17, 2025 Filed Nov 18, 2025
  11. Joshua J. Ofman President
    Planned sale
    $1.2M 14,979 shares at $78.47 3.8% of stake
    Traded Oct 15–16 Filed Oct 16, 2025

Also filed in the last 12 months, not counted as buying or selling: 21 sales to cover taxes, 20 stock grants, and 1 option exercise.

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
SCHEDULE 13G —
10-Q
SCHEDULE 13G/A —
8-K 2.02,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
SCHEDULE 13G/A —
8-K 5.07
8-K 5.02,8.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
DEF 14A
DEFA14A

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf